Insider Trading activities of Adamas Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adamas Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adamas Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Adamas Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ADMS. The reporting company's CIK number is 1328143.
The total value of stock buying since 2005 is $17,718,586.
The total value of stock sales since 2005 is $26,979,738.
The total value of stock option exercises since 2005 is $553,225.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Adamas Pharmaceuticals Inc (ADMS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 0 $0 381,041 $6,507,412 0 $0
2017-03 0 $0 4,256 $72,479 0 $0
2016-09 518,236 $8,118,586 0 $0 0 $0
2016-06 0 $0 0 $0 204,900 $384,187
2016-04 0 $0 36,000 $666,000 36,000 $43,560
2015-12 0 $0 3,000 $48,690 0 $0
2015-11 0 $0 3,000 $45,000 0 $0
2015-10 0 $0 3,000 $50,250 0 $0
2015-09 0 $0 3,000 $57,390 0 $0
2015-08 0 $0 3,000 $73,530 0 $0
2015-07 0 $0 77,988 $2,143,014 0 $0
2015-06 0 $0 37,684 $983,522 2,000 $3,510
2015-05 0 $0 251,126 $4,520,690 12,628 $23,436
2015-04 0 $0 108,796 $1,944,505 7,552 $13,918
2015-03 0 $0 402,834 $6,976,714 20,920 $38,984
2015-02 0 $0 6,000 $100,590 2,000 $3,510
2015-01 0 $0 6,000 $105,380 2,000 $3,510
2014-12 0 $0 148,440 $2,158,221 22,000 $38,610
2014-11 0 $0 35,560 $526,351 0 $0
2014-04 600,000 $9,600,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Adamas Pharmaceuticals Inc insiders (ADMS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-21 Rhodes Jennifer J (CBO, GC & Compliance Officer) Sale 1,041 17.54 18,253
2017-06-21 Kroin David Sale 10,000 17.44 174,370
2017-06-20 Kroin David Sale 20,000 17.35 346,940
2017-06-19 Kroin David Sale 350,000 17.05 5,967,849
2017-03-21 Patni Rajiv (Chief Medical Officer) Sale 733 17.04 12,490
2017-03-21 Went Gregory T (Chief Executive Officer) Sale 2,807 17.03 47,803
2017-03-21 Dawson William J (Chief Financial Officer) Sale 716 17.02 12,186
2016-09-16 Ericson William W. (Director) Buy 8,240 16.81 138,497
2016-09-16 Mdv Vii Lp (10% Owner) Buy 8,240 16.81 138,497
2016-09-15 Ericson William W. (Director) Buy 200 16.50 3,300
2016-09-15 Mdv Vii Lp (10% Owner) Buy 200 16.50 3,300
2016-09-14 Ericson William W. (Director) Buy 54,537 16.43 895,770
2016-09-14 Mdv Vii Lp (10% Owner) Buy 54,537 16.43 895,770
2016-09-13 Ericson William W. (Director) Buy 62,034 15.56 965,000
2016-09-13 Mdv Vii Lp (10% Owner) Buy 62,034 15.56 965,000
2016-09-12 Ericson William W. (Director) Buy 22,342 15.65 349,741
2016-09-12 Mdv Vii Lp (10% Owner) Buy 22,342 15.65 349,741
2016-09-07 Ericson William W. (Director) Buy 60,846 15.68 954,065
2016-09-07 Mdv Vii Lp (10% Owner) Buy 60,846 15.68 954,065
2016-09-06 Ericson William W. (Director) Buy 7,200 15.00 107,978
2016-09-06 Mdv Vii Lp (10% Owner) Buy 7,200 15.00 107,978
2016-09-02 Ericson William W. (Director) Buy 43,719 14.75 644,942
2016-09-02 Mdv Vii Lp (10% Owner) Buy 43,719 14.75 644,942
2016-06-15 Went Gregory T (Chief Executive Officer) Option Ex 204,900 1.88 384,187
2016-04-18 Mcclure Natalie (SVP, Product Development) Sale 36,000 18.50 666,000
2016-04-18 Mcclure Natalie (SVP, Product Development) Option Ex 36,000 1.21 43,560
2015-12-07 Lieberburg Ivan M (Director) Sale 3,000 16.23 48,690
2015-11-02 Lieberburg Ivan M (Director) Sale 3,000 15.00 45,000
2015-10-05 Lieberburg Ivan M (Director) Sale 3,000 16.75 50,250
2015-09-08 Lieberburg Ivan M (Director) Sale 3,000 19.13 57,390
2015-08-03 Lieberburg Ivan M (Director) Sale 3,000 24.51 73,530
2015-07-10 Ericson William W. (Director) Sale 8,657 27.53 238,309
2015-07-10 Mdv Vii Lp (10% Owner) Sale 8,657 27.53 238,309
2015-07-08 Ericson William W. (Director) Sale 3,100 27.55 85,408
2015-07-08 Mdv Vii Lp (10% Owner) Sale 3,100 27.55 85,408
2015-07-07 Ericson William W. (Director) Sale 25,737 27.55 708,925
2015-07-07 Mdv Vii Lp (10% Owner) Sale 25,737 27.55 708,925
2015-07-06 Lieberburg Ivan M (Director) Sale 3,000 25.91 77,730
2015-06-18 Ericson William W. (Director) Sale 15,842 27.54 436,256
2015-06-18 Mdv Vii Lp (10% Owner) Sale 15,842 27.54 436,256
2015-06-15 Booth Richard H (Director) Sale 1,000 19.32 19,320
2015-06-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 18.95 37,900
2015-06-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-06-01 Lieberburg Ivan M (Director) Sale 3,000 17.93 53,790
2015-05-29 Ericson William W. (Director) Sale 112,073 18.02 2,019,555
2015-05-29 Mdv Vii Lp (10% Owner) Sale 112,073 18.02 2,019,555
2015-05-28 Ericson William W. (Director) Sale 7,483 18.02 134,821
2015-05-28 Mdv Vii Lp (10% Owner) Sale 7,483 18.02 134,821
2015-05-18 Ericson William W. (Director) Sale 1,643 18.04 29,639
2015-05-18 Mdv Vii Lp (10% Owner) Sale 1,643 18.04 29,639
2015-05-15 Booth Richard H (Director) Sale 1,000 17.85 17,850
2015-05-14 Went Gregory T (Chief Executive Officer) Sale 300 18.00 5,400
2015-05-14 Went Gregory T (Chief Executive Officer) Option Ex 100 1.88 187
2015-05-13 Went Gregory T (Chief Executive Officer) Sale 128 18.00 2,304
2015-05-13 Went Gregory T (Chief Executive Officer) Option Ex 10,028 1.88 18,802
2015-05-12 Went Gregory T (Chief Executive Officer) Sale 2,300 18.00 41,406
2015-05-12 Went Gregory T (Chief Executive Officer) Option Ex 500 1.88 937
2015-05-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 17.62 35,240
2015-05-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-05-04 Lieberburg Ivan M (Director) Sale 3,000 16.82 50,460
2015-04-23 Went Gregory T (Chief Executive Officer) Sale 3,300 18.00 59,406
2015-04-23 Went Gregory T (Chief Executive Officer) Option Ex 900 1.88 1,687
2015-04-21 Went Gregory T (Chief Executive Officer) Sale 2,773 18.00 49,925
2015-04-21 Went Gregory T (Chief Executive Officer) Option Ex 962 1.88 1,803
2015-04-20 Went Gregory T (Chief Executive Officer) Sale 7,810 18.00 140,580
2015-04-20 Went Gregory T (Chief Executive Officer) Option Ex 2,610 1.88 4,893
2015-04-15 Booth Richard H (Director) Sale 1,000 17.72 17,720
2015-04-14 Went Gregory T (Chief Executive Officer) Sale 10,180 12.62 128,522
2015-04-14 Went Gregory T (Chief Executive Officer) Option Ex 80 1.88 150
2015-04-10 Went Gregory T (Chief Executive Officer) Sale 4,577 18.58 85,040
2015-04-10 Went Gregory T (Chief Executive Officer) Option Ex 1,000 1.88 1,875
2015-04-10 Ericson William W. (Director) Sale 37,078 18.56 688,056
2015-04-10 Mdv Vii Lp (10% Owner) Sale 37,078 18.56 688,056
2015-04-06 Mcclure Natalie (SVP, Product Development) Sale 2,000 17.44 34,880
2015-04-06 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-04-06 Lieberburg Ivan M (Director) Sale 3,000 17.44 52,320
2015-03-20 Went Gregory T (Chief Executive Officer) Sale 300 18.00 5,400
2015-03-20 Went Gregory T (Chief Executive Officer) Option Ex 100 1.88 187
2015-03-19 Went Gregory T (Chief Executive Officer) Sale 4,468 18.00 80,424
2015-03-19 Went Gregory T (Chief Executive Officer) Option Ex 12,320 1.88 23,100
2015-03-18 Went Gregory T (Chief Executive Officer) Sale 14,020 18.00 252,402
2015-03-18 Went Gregory T (Chief Executive Officer) Option Ex 4,600 1.88 8,625
2015-03-18 Ericson William W. (Director) Sale 7,200 18.04 129,895
2015-03-18 Mdv Vii Lp (10% Owner) Sale 7,200 18.04 129,895
2015-03-17 Went Gregory T (Chief Executive Officer) Sale 4,600 18.00 82,800
2015-03-17 Went Gregory T (Chief Executive Officer) Option Ex 1,900 1.88 3,562
2015-03-17 Ericson William W. (Director) Sale 4,523 18.00 81,414
2015-03-17 Mdv Vii Lp (10% Owner) Sale 4,523 18.00 81,414
2015-03-16 Booth Richard H (Director) Sale 1,000 17.36 17,360
2015-03-13 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 350,000 17.23 6,030,500
2015-03-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 17.15 34,300
2015-03-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-03-02 Lieberburg Ivan M (Director) Sale 3,000 16.97 50,910
2015-02-17 Booth Richard H (Director) Sale 1,000 16.54 16,540
2015-02-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 16.87 33,740
2015-02-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-02-02 Lieberburg Ivan M (Director) Sale 3,000 16.77 50,310
2015-01-15 Booth Richard H (Director) Sale 1,000 17.43 17,430
2015-01-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 17.59 35,180
2015-01-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2015-01-05 Lieberburg Ivan M (Director) Sale 3,000 17.59 52,770
2014-12-24 Booth Richard H (Director) Sale 2,000 17.51 35,020
2014-12-05 Mcclure Natalie (SVP, Product Development) Sale 2,000 14.01 28,028
2014-12-05 Mcclure Natalie (SVP, Product Development) Option Ex 2,000 1.75 3,510
2014-12-03 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 105,225 14.51 1,526,288
2014-12-02 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 6,400 14.51 92,889
2014-12-01 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 12,815 14.51 185,996
2014-12-01 Mcclure Natalie (SVP, Product Development) Sale 20,000 14.50 290,000
2014-12-01 Mcclure Natalie (SVP, Product Development) Option Ex 20,000 1.75 35,100
2014-11-28 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 800 14.93 11,940
2014-11-26 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 12,500 14.77 184,662
2014-11-25 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 5,600 14.85 83,171
2014-11-24 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 4,400 14.86 65,370
2014-11-21 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 8,760 14.81 129,779
2014-11-20 Aeris Capital Equity Investments, L.p. (10% Owner) Sale 3,500 14.69 51,429
2014-04-15 Mdv Vii Leaders' Fund, L.p. (10% Owner) Buy 300,000 16.00 4,800,000
2014-04-15 Ericson William W. (Director) Buy 300,000 16.00 4,800,000

Insider trading activities including stock purchases, stock sales, and option exercises of ADMS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adamas Pharmaceuticals Inc (symbol ADMS, CIK number 1328143) see the Securities and Exchange Commission (SEC) website.